FDA Inspection 1267841 — Alexis Baass
The FDA completed an inspection of Alexis Baass on Apr 2, 2025 in Montreal. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 2, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Montreal (Canada)
Additional details
Clinical Investigator (CI)